
WASHINGTON, March 20 (UPI) -- The U.S. Food and Drug Administration has approved a new injectable drug, Treanda, for the treatment of chronic lymphocytic leukemia.
Pharmaceutical manufacturer Cephalon Inc. of Frazer, Pa., said Treanda (bendamustine hydrochloride) received priority review by the FDA and was approved within six months of the company's application.
Chronic lymphocytic leukemia, or CLL, is a slowly progressing blood and bone marrow disease. The American Cancer Society estimates more than 15,000 new cases of the rare disease will be diagnosed in the United States this year.
Cephalon officials said they anticipate Treanda will become available to physicians and patients as a CLL treatment in the United States next month.
Treanda has also been granted orphan drug status by the FDA, thereby providing Cephalon with marketing exclusivity until March 2015.
|
|
|
|
|
|
| Additional Science News Stories | |
WASHINGTON, Feb. 10 (UPI) --
Republican presidential contender Mitt Romney told a conservative audience in Washington Friday he would make sweeping changes to Medicare and Social Security.
|
NEW YORK, Feb. 10 (UPI) --
U.S. recording stars Jay-Z and Beyonce have posted photos of their 4-week-old daughter at HelloBlueIvyCarter.tumblr.com.
|
ATHENS, Ga., Feb. 10 (UPI) --
Studies of the genome of Miscanthus, a large perennial grass, could speed the development of biofuels derived from the plant, U.S. researchers say.
|
Police: One-legged man hid cocaine in butt ... Man sent pictures of stolen panties ... Company tattoos hair onto bald men ... Artist slims down Renaissance paintings ... UPI Quirks in the News.
|
| Stories | Photos | People | Comments |
View Caption